Organization: Health Canada
Year: 2023
Month: July
Request Number: A-2022-001655
Request Summary: Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate which was accepted into review on or after December 1, 2022. Provide: the month and year that this desmopressin ANDS was accepted into review; and the status of this desmopressin ANDS’ review.
Disposition: Disclosed in part
Number of pages: 1